Synthetic Biology

Biomatter Secures $18 Million for AI-Powered Enzyme Design
Biotech & Bioprocessing Biomatter Secures $18 Million for AI-Powered Enzyme Design

Suboptimal enzymes have long been the industry standard because the technology to design specific target reactions from scratch was previously unavailable. This technical ceiling has restricted progress across the pharmaceutical and agricultural sectors for decades, forcing scientists to rely on

Will the New National Biosecurity Policy Stop AI Pathogens?
Biotech & Bioprocessing Will the New National Biosecurity Policy Stop AI Pathogens?

Federal research institutions face a five-year ban on government funding if they fail to procure synthetic DNA from certified providers under the new biosecurity directive. This high-stakes ultimatum serves as the cornerstone of Memorandum NSTM-6, issued on November 5, 2026, by the White House

Engineered Bacteria Turn Food Waste Water Into Hydrogen
Biotech & Bioprocessing Engineered Bacteria Turn Food Waste Water Into Hydrogen

Biological hydrogen generation is often considered economically unfeasible because of the high costs associated with synthetic growth media and feedstocks. Despite this, the global push for a decarbonized energy grid has turned hydrogen into a critical focal point, primarily because its energy

What Is the Future of Keratin in Tissue Engineering?
Biotech & Bioprocessing What Is the Future of Keratin in Tissue Engineering?

The future of regenerative medicine may depend on refining extraction processes to preserve higher-molecular-weight proteins within hybrid keratin-based systems. As the medical community faces an escalating global shortage of donor organs and tissues, the search for sustainable, bioactive

Strengthening Biosafety With a Human Capital Framework
Management & Regulatory Strengthening Biosafety With a Human Capital Framework

Practical experiments in ethics-integrated education are essential for developing a workforce capable of navigating the moral complexities of modern genetic engineering. As synthetic biology moves from the theoretical confines of academic research into the rapid-fire pace of industrial

Can B-SYNC CAR-T Therapy Cure Fatal Childhood Brain Cancer?
Research & Development Can B-SYNC CAR-T Therapy Cure Fatal Childhood Brain Cancer?

Engineering T-cells to recognize multiple antigens allows the treatment to remain effective even if some tumor cells stop expressing one of the targeted markers. For families facing a pediatric Diffuse Midline Glioma (DMG) diagnosis, the news is historically grim, as this aggressive cancer

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later